Brief: Axovant Announces Q1 Loss Per Share $0.20

Sio Gene Therapies

11/08/2020 12:59

Aug 11 (Reuters) - Axovant Gene Therapies Ltd  AXGT.O :
    * AXOVANT ANNOUNCES CORPORATE UPDATES AND FINANCIAL RESULTS
FOR
FIRST FISCAL QUARTER ENDED JUNE 30, 2020
    * Q1 LOSS PER SHARE $0.20
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.44 -- REFINITIV IBES
DATA
    * DATA READOUTS FOR AXO-LENTI-PD AND AXO-AAV-GM1 REMAIN
ON-TRACK
FOR Q4 2020
    * EXPECT CASH AND CASH EQUIVALENTS TO SUSTAIN OPERATIONS
INTO
SECOND CALENDAR QUARTER OF 2021

Source text for Eikon:  ID:nGNX71pzCf 
Further company coverage:  AXGT.O 

 ((Reuters.Briefs@thomsonreuters.com;))